ConductScience.org, home

Paper2869952

Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.

M'Buyamba-Kabangu JR and 6 others. Eur J Clin Pharmacol, 1986. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients. Papers, record 2869952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2869952

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1986
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2026-10-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1M'Buyamba-Kabangu JRJ R
2Lepira BB
3Fagard RR
4Lijnen PP
5Ditu MM
6Tshiani KAK A
7Amery AA

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
Antihypertensive AgentsMajor topic
Calcium Channel BlockersMajor topic
HypertensionMajor topic
Acebutolol
Adolescent
Adult
Black or African American
Aged
Body Weight
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Middle Aged
Nifedipine
Nitrendipine
Pulse
Random Allocation
Renin
Time Factors

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13158325The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3158325PubMed
2738346Acute and chronic effects of nifedipine in arterial hypertension.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/738346PubMed
34303266Suppressed plasma renin activity in hypertension.Arch Intern Med1969https://conductscience.org/library/papers/4303266PubMed
46803871Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6803871PubMed
5353597The treatment of hypertension with verapamil.N Z Med J1978https://conductscience.org/library/papers/353597PubMed
6371856Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation1979https://conductscience.org/library/papers/371856PubMed
76134671Comparison of beta-adrenoceptor blockers and calcium antagonists in hypertension.Hypertension1983https://conductscience.org/library/papers/6134671PubMed
87000296Trial of atenolol and chlorthalidone for hypertension in black South Africans.Br Med J1980https://conductscience.org/library/papers/7000296PubMed
94871610Ineffectiveness of propranolol in hypertensive Jamaicans.Br Med J1968https://conductscience.org/library/papers/4871610PubMed
106738760Intracellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of normal male subjects. Effect of family history of hypertension and race.Neth J Med1984https://conductscience.org/library/papers/6738760PubMed
116184573Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine.J Cardiovasc Pharmacol1982https://conductscience.org/library/papers/6184573PubMed
125697693Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm.Circulation1968https://conductscience.org/library/papers/5697693PubMed
136339109The effect of nifedipine on arterial pressure and reflex cardiac control.Circulation1983https://conductscience.org/library/papers/6339109PubMed
14676983Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.Am Heart J1978https://conductscience.org/library/papers/676983PubMed
156184574Experience with nitrendipine--a new calcium antagonist--in hypertension.J Cardiovasc Pharmacol1982https://conductscience.org/library/papers/6184574PubMed
16618641Faster radioimmunoassay of angiotensin I at 37 degrees C.Clin Chem1978https://conductscience.org/library/papers/618641PubMed
175084985Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.N Engl J Med1972https://conductscience.org/library/papers/5084985PubMed
18629266The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol.Am J Med1978https://conductscience.org/library/papers/629266PubMed
194257928Essential hypertension: renin and aldosterone, heart attack and stroke.N Engl J Med1972https://conductscience.org/library/papers/4257928PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
3552592Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.Drugs1987https://conductscience.org/library/papers/3552592PubMed
3154705Calcium channel antagonists. Part V: Second-generation agents.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154705PubMed
3154329Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154329PubMed
1283579Choosing the correct drug for the individual hypertensive patient.Drugs1992https://conductscience.org/library/papers/1283579PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2869952

GET https://conductscience.org/api/papers/v1/2869952/authors